检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:程振田[1] 周芸 袁祥萍[1] 单丽妮[1] CHENG Zhentian;ZHOU Yun;YUAN Xiangping;SHAN Lini(Yidu Central Hospital of Weifang,Weifang 262500,China)
出 处:《药学研究》2021年第10期694-697,共4页Journal of Pharmaceutical Research
基 金:山东省药品不良反应监测中心委托项目(No.药械化-2020-SDADRKY02)。
摘 要:目的探讨运用PDCA循环在促进我院药品不良反应(ADR)报告和监测中的效果,提高我院药品不良反应报告和监测工作的规范化及标准化,促进临床用药安全。方法通过分析我院2017—2020年的药品不良反应报告数量和类型,评价自2019年运用PDCA循环进行干预后监测效果的变化。结果运用PDCA循环进行干预后,我院药品不良反应上报数量、新/严数量及病程记录率均有所提高。结论PDCA循环的干预,明显提高我院药品不良反应监测水平。Objective To explore the effect of applying the PDCA cycle in hospital adverse drug reaction(ADR)reporting and monitoring,to improve the standardization of ADR reporting and monitoring in our hospital,and to promote the safety of clinical medication.Methods Analyze the quantity and quality fo ADR reporting and monitoring of our hospital in 2017—2020,evaluate the effect of applying the PDCA cycle method since 2019.Results After the PDCA cycle′s application,the quantity of reported ADR,new/serious ADR reports′quantity and the record rate of the course of the disease increased.Conclusion The intervention of PDCA cycle has significantly improved the quality of ADR monitoring in our hospital,which will help reduce the risk of clinical medication and ensure the safety of patients′medication.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117